Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (JP:4519)
TSE/TYO:4519
Holding JP:4519?
Track your performance easily
4519 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥4,197.00 - ¥7,485.00
Previous Close¥6,808
Volume1.72M
Average Volume (3M)2.71M
Market Cap
¥11.19T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)31.6
Beta0.84
Next Earnings
Oct 25, 2024EPS Estimate
¥60.2Next Dividend Ex-Date
Dec 27, 2024Dividend Yield1.12%
Share Statistics
EPS (TTM)215.78
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume2,712,320
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥7,116.12Price Target Upside4.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Chugai Pharmaceutical Co News
PremiumCompany Announcements
Chugai Pharmaceutical Corrects Financial Statements
PremiumCompany Announcements
Chugai Pharmaceutical’s H1 Profits and Dividends Up
PremiumCompany Announcements
Chugai Pharmaceutical Included in Roche’s 2024 Results
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
3.57% Mutual Funds
3.83% Other Institutional Investors
92.60% Public Companies and
Individual Investors
4519 FAQ
What was Chugai Pharmaceutical Co Ltd’s price range in the past 12 months?
Chugai Pharmaceutical Co Ltd lowest stock price was ¥4197.00 and its highest was ¥7485.00 in the past 12 months.
What is Chugai Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Chugai Pharmaceutical Co Ltd’s upcoming earnings report date?
Chugai Pharmaceutical Co Ltd’s upcoming earnings report date is Oct 25, 2024 which is in 34 days.
How were Chugai Pharmaceutical Co Ltd’s earnings last quarter?
Chugai Pharmaceutical Co Ltd released its earnings results on Jul 25, 2024. The company reported ¥67.98 earnings per share for the quarter, beating the consensus estimate of ¥54.057 by ¥13.923.
Is Chugai Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Chugai Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Chugai Pharmaceutical Co Ltd pay dividends?
Chugai Pharmaceutical Co Ltd pays a Annually dividend of ¥41 which represents an annual dividend yield of 1.12%. See more information on Chugai Pharmaceutical Co Ltd dividends here
What is Chugai Pharmaceutical Co Ltd’s EPS estimate?
Chugai Pharmaceutical Co Ltd’s EPS estimate is ¥60.2.
How many shares outstanding does Chugai Pharmaceutical Co Ltd have?
Chugai Pharmaceutical Co Ltd has 1,679,057,600 shares outstanding.
What happened to Chugai Pharmaceutical Co Ltd’s price movement after its last earnings report?
Chugai Pharmaceutical Co Ltd reported an EPS of ¥67.98 in its last earnings report, beating expectations of ¥54.057. Following the earnings report the stock price went down -2.207%.
Which hedge fund is a major shareholder of Chugai Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in JP:4519
---
Chugai Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
59.20%
12-Months-Change
Fundamentals
Return on Equity
22.21%
Trailing 12-Months
Asset Growth
1.06%
Trailing 12-Months
Company Description
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
---
4519 Company Deck
---
4519 Earnings Call
Q2 2024
0:00 / 0:00
---
4519 Stock 12 Month Forecast
Average Price Target
¥7,116.12
▲(4.53% Upside)
Technical Analysis
Vertex Pharmaceuticals
―
Regeneron
―
Alnylam Pharma
―
Biogen
―
Chugai Pharmaceutical Co
―
Best Analysts Covering 4519
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+32.40%
reiterated a buy rating 2 months ago
Copying Stephen Barker's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +32.40% per trade.
---